AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 9200356
Drug: rhSOD treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhSOD treatment groups
Trial: 15277161
Drug: Reduced-fat salad
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reduced-fat salad dressing (6 g canola oil)
Trial: 15277161
Drug: Full-fat salad
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full-fat salad dressing (28 g canola oil)
Trial: 15277161
Drug: Fat-free salad
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fat-free salad dressing (0 g canola oil)
Trial: 10932511
Drug: Norgestrel 0.5
RxNorm normalized name: norgestrel 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Norgestrel 0.5 mg/day
Trial: 9059197
Drug: Extradural morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extradural morphine 0.06 mg kg‐1 at the end of surgery and a second dose 6 h later
Trial: 9059197
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups received PCA with morphine 0.04 mg kg‐1 i.v.
Trial: 1637513
Drug: Conventional antihypertensive
RxNorm normalized name: ANTIHYPERTENSIVES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional antihypertensive treatment
Trial: 3732360
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg mexiletine
Trial: 3732360
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg disopyramide
Trial: 12576305
Drug: Ginger pretreatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginger pretreatment (1,000 and 2,000 mg)
Trial: 12576305
Drug: Intravenous vasopressin
RxNorm normalized name: Vasopressin
DrugBank: Vasopressin (DB00067)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous vasopressin infusion (0.1 and 0.2 U/min)
Trial: 9051704
Drug: Simvastatin at
RxNorm normalized name: Simvastatin
DrugBank: Simvastatin (DB00641)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Simvastatin at standard therapeutic doses
Trial: 24240575
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D (1000 IU daily of cholecalciferol combined with 100 mg of elemental calcium administered twice a day)
Trial: 19702643
Drug: Total Therapy
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total Therapy 2 (TT2)
Trial: 18302711
Drug: Total Therapy
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total Therapy 3 (TT3) for patients completing TT2 consolidation within 24 months
Trial: 12462290
Drug: Fenofibrate 300
RxNorm normalized name: fenofibrate 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenofibrate 300 mg once daily for 8 weeks
Trial: 10478810
Drug: Amrinone (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amrinone (1 mg/kg)
Trial: 2675219
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no drug administered)
Trial: 1878318
Drug: Conditioned startle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conditioned startle reflex augmentation.
Trial: 30497077
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no music therapy)
Trial: 26494411
Drug: Once daily
RxNorm normalized name: GEL, ONCE DAILY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once daily thoracic radiotherapy (TRT) of 42 Gy in 15 fractions (OD)
Trial: 26494411
Drug: Twice daily
RxNorm normalized name: CAPSULE, TWICE DAILY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice daily thoracic radiotherapy (TRT) of 45 Gy in 30 fractions (BID)
Trial: 24907435
Drug: MP0112 (0.04
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MP0112 (0.04 to 3.6 mg, single intravitreal injection)
Trial: 24907435
Drug: MP0112 (0.04-0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MP0112 (0.04-0.4 mg)
Trial: 24907435
Drug: MP0112 (1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MP0112 (1.0 or 2.0 mg)
Trial: 24907435
Drug: MP0112 (higher-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MP0112 (higher-dose cohorts)
Trial: 22294470
Drug: Midostaurin (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midostaurin (75 mg twice daily for 2 days; 75 mg once on day 3)
Trial: 20817247
Drug: 0.5 mL
RxNorm normalized name: ethanol 0.5 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mL sterile water
Trial: 20817247
Drug: 0.5 mL
RxNorm normalized name: ethanol 0.5 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mL 24% sucrose solution
Trial: 12000209
Drug: Phenylpropanolamine (PPA)
DrugBank: Phenylpropanolamine (DB00397)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Phenylpropanolamine (PPA) 75 mg/day
Trial: 7638640
Drug: Mitomycin 12
RxNorm normalized name: Mitomycin
DrugBank: Mitomycin (DB00305)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mitomycin 12 mg/m2 given as an intravenous infusion every 6 weeks
Trial: 2199599
Drug: Single-dose 500-mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose 500-mg clotrimazole vaginal tablets
Trial: 28813414
Drug: Oral synbiotic
RxNorm normalized name: Synotic
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral synbiotic preparation (Lactobacillus plantarum plus fructooligosaccharide)
Trial: 21527122
Drug: Vilazodone (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vilazodone (40 mg/d)
Trial: 19056600
Drug: Rye bran
RxNorm normalized name: bran
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rye bran flakes containing 44 mg total ARs
Trial: 11527284
Drug: Extended treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended treatment protocol including individual certified nursing assistants (CNAs), in-service training for CNAs, and memory notebooks.
Trial: 9815587
Drug: Continuous-infusion vinblastine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous-infusion vinblastine alone (1.2 mg/m2/day for 4 days or 1.5 mg/m2/day for 5 days)
Trial: 28499391
Drug: Chondrosphere® (low
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chondrosphere® (low dose: 3-7 spheroids/cm², medium dose: 10-30 spheroids/cm², high dose: 40-70 spheroids/cm²)
Trial: 28499391
Drug: Chondrosphere® (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chondrosphere® (all dose levels)
Trial: 1319311
Drug: Oral itraconazole,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral itraconazole, 200 mg twice daily
Trial: 1319311
Drug: Intravenous amphotericin
RxNorm normalized name: amphotericin
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous amphotericin B, 0.6 mg/kg/day (or 0.3 mg/kg/day plus flucytosine, 150 mg/kg/day for some Candida infections)
Trial: 6230612
Drug: naproxen-sodium (825
FDA approved: no
EMA approved: no
PMDA approved: no
Description: naproxen-sodium (825 mg)
Trial: 6230612
Drug: paracetamol (1,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: paracetamol (1,000 mg)
Trial: 26925771
Drug: Training in
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Training in Evidence-Based Medicine (EBM) for 6 months
Trial: 18853138
Drug: Bile acids
RxNorm normalized name: Conjugated bile acids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bile acids (5 micromol/l)
Trial: 15616226
Drug: Ultralente insulin
RxNorm normalized name: ultralente insulin, beef
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultralente insulin
Trial: 16035063
Drug: Low-dose HCIG
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose HCIG (75 mg/kg)
Trial: 16035063
Drug: High-dose HCIG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose HCIG (200 mg/kg)
Trial: 10417490
Drug: Activated charcoal
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Activated charcoal combined with gastric lavage (25 g charcoal after lavage)
Trial: 10417490
Drug: Activated charcoal
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Activated charcoal alone (25 g in 200 ml water)
Trial: 10954340
Drug: Control (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (200 ml water)
Trial: 18045712
Drug: Flavonoid-rich dark
RxNorm normalized name: dark leaved mugwort pollen extract
DrugBank: Artemisia ludoviciana pollen (DB10762)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flavonoid-rich dark chocolate (Meiji Black Chocolate 45 g, 550 mg cacao polyphenol/day, 200 kcal)
Trial: 18045712
Drug: Non-flavonoid white
RxNorm normalized name: White Petrolatum
DrugBank: Petrolatum (DB11058)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-flavonoid white chocolate (Meiji White Chocolate 35 g, 0 mg cacao polyphenol/day, 140 kcal)
Trial: 11197288
Drug: RAP150 group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RAP150 group (pantoprazole 40 mg b.i.d., amoxycillin 1 g b.i.d., rifabutin 150 mg o.d.)
Trial: 11197288
Drug: RAP300 group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RAP300 group (pantoprazole 40 mg b.i.d., amoxycillin 1 g b.i.d., rifabutin 300 mg o.d.)
Trial: 11197288
Drug: QT group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: QT group (pantoprazole 40 mg b.i.d., metronidazole 250 mg t.i.d., bismuth citrate 240 mg b.i.d., tetracycline 500 mg q.i.d.)
Trial: 11197288
Drug: Quadruple therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quadruple therapy patients
Trial: 2673437
Drug: Tetracosactide (TCS)
RxNorm normalized name: tetracosactide
DrugBank: Tetracosactide (DB01284)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tetracosactide (TCS) 2 mg
Trial: 2673437
Drug: Dexamethasone (DXM)
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dexamethasone (DXM) 20 mg
Trial: 339647
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg L-dopa
Trial: 339647
Drug: 0.75 mg
RxNorm normalized name: propinox 0.75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.75 mg apomorphine
Trial: 31094354
Drug: Psychoeducational mobile
RxNorm normalized name: Chamaemelum nobile extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychoeducational mobile app plus treatment as usual (TAU)
Trial: 9503814
Drug: Isoptin-retard (240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoptin-retard (240 mg/day)
Trial: 10219807
Drug: Radiotherapy treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiotherapy treatment
Trial: 23297639
Drug: Lactulose administration
RxNorm normalized name: Lactulose
DrugBank: Lactulose (DB00581)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Lactulose administration (30 ml for 1 week)
Trial: 18503891
Drug: Statin administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin administration (Atorvastatin and Pravastatin)
Trial: 22246178
Drug: Statin administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin administration
Trial: 8277950
Drug: Low sucrose
RxNorm normalized name: Sucrose
DrugBank: Sucrose (DB02772)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Low sucrose diet with saccharin (12 +/- 4.5 mg/kg/day)
Trial: 8011799
Drug: Dexamethasone (DEX)
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dexamethasone (DEX) 0.5 mg
Trial: 2923936
Drug: Dexamethasone (DEX)
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dexamethasone (DEX) 1.0 mg
Trial: 2923936
Drug: Standard 1.0‐mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard 1.0‐mg DST
Trial: 1934546
Drug: Intramuscular diclofenac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular diclofenac
Trial: 16461878
Drug: Ibuprofen (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen (5 mg/kg per dose every 8 hours)
Trial: 16461878
Drug: Alternating acetaminophen
RxNorm normalized name: Acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternating acetaminophen and ibuprofen (every 4 hours)
Trial: 8312728
Drug: Inpatient or
RxNorm normalized name: Impatiens irvingii whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inpatient or residential treatment
Trial: 25380193
Drug: Tiotropium 2.5
RxNorm normalized name: TIOTROPIUM 2.5MCG/ACTUAT 60D ORAL INHL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiotropium 2.5 μg inhaled via Respimat® Soft Mist™ Inhaler
Trial: 25380193
Drug: Tiotropium (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiotropium (2.5 μg or 5 μg)
Trial: 9409295
Drug: Transdermal estradiol
RxNorm normalized name: estradiol Transdermal System
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal estradiol combined with progesterone
Trial: 8746882
Drug: No hormonal
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No hormonal treatment
Trial: 8287641
Drug: II (insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: II (insulin infusion only)
Trial: 2882967
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment (90 adults and 42 adolescents)
Trial: 31287236
Drug: Coadministration of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coadministration of gemfibrozil 600 mg BID with brigatinib 90 mg
Trial: 31287236
Drug: Coadministration of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coadministration of itraconazole 200 mg BID with brigatinib 90 mg
Trial: 31287236
Drug: Coadministration of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coadministration of rifampin 600 mg QD with brigatinib 180 mg
Trial: 3582476
Drug: Meptazinol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meptazinol (100 mg)
Trial: 6403933
Drug: Morphine (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (15 mg)
Trial: 10491528
Drug: Continuous oral
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous oral conjugated equine estrogen (ERT)
Trial: 8686714
Drug: Low-dose dopamine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose dopamine (< 3 micrograms/kg/min)
Trial: 1897377
Drug: Physostigmine (acute,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physostigmine (acute, intravenous administration)
Trial: 6344699
Drug: Epidural morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural morphine (5 mg preservative-free morphine sulfate in 10 ml saline)
Trial: 8485789
Drug: Epidural morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural morphine
Trial: 12623939
Drug: Nifedipine 30
RxNorm normalized name: nifedipine 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine 30 mg once daily
Trial: 1662562
Drug: Lisinopril 10
RxNorm normalized name: lisinopril 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisinopril 10 mg once daily
Trial: 7959378
Drug: Invasive hemodynamic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Invasive hemodynamic monitoring and treatment before operation (group A)
Trial: 28735368
Drug: MDMA (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MDMA (75 mg)
Trial: 18201352
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of calcipotriol or maxacalcitol ointment before phototherapy
Trial: 18201352
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of calcipotriol or maxacalcitol ointment after phototherapy
Trial: 30808949
Drug: Extensively hydrolyzed
RxNorm normalized name: collagen, hydrolyzed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extensively hydrolyzed casein formula containing the probiotic L.rhamnosus GG (EHCF + LGG)
Trial: 28181192
Drug: Dual-pill combination
RxNorm normalized name: Tums Dual Action Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual-pill combination of perindopril 5 mg/indapamide 1.25 mg + amlodipine 5 mg (Per/Ind + Aml)
Trial: 23190017
Drug: Fostamatinib suspension
RxNorm normalized name: fostamatinib
DrugBank: Fostamatinib (DB12010)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Fostamatinib suspension
Trial: 23190017
Drug: Fostamatinib tablet
RxNorm normalized name: fostamatinib
DrugBank: Fostamatinib (DB12010)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Fostamatinib tablet
Trial: 16527796
Drug: NTI under
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: NTI under curve-tipped suction catheter (CTSC) guidance (G[+] group)
Trial: 16527796
Drug: NTI without
RxNorm normalized name: threonine
DrugBank: Threonine (DB00156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: NTI without CTSC guidance (G[‐] group)
Trial: 7020093
Drug: Niclofolan 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Niclofolan 2 mg/kg
Trial: 23823347
Drug: Chemomechanical method
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemomechanical method (papain gel)
Trial: 18851956
Drug: Atorvastatin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin (10 mg/day for 4 weeks)
Trial: 8708970
Drug: Systemic beta-blockers
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic beta-blockers
Trial: 7062419
Drug: Cyclophosphamide, methotrexate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclophosphamide, methotrexate and 5-fluorouracil combination chemotherapy
Trial: 19794082
Drug: Vorinostat (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vorinostat (200 mg three times daily for 14 days followed by 1 week rest) in arm B
Trial: 15547458
Drug: naltrexone 50
RxNorm normalized name: naltrexone 50 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: naltrexone 50 mg daily plus usual program treatment
Trial: 15547458
Drug: placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: placebo plus usual treatment
Trial: 9000657
Drug: HAT 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HAT 0.5 mg/kg/week (n=4)
Trial: 9000657
Drug: HAT 1
RxNorm normalized name: brompheniramine maleate/pseudoephedrine HCl/codeine phosphat 1.3 mg-10 mg-6.3 mg/5 mL ORAL LIQUID (ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HAT 1 mg/kg/week (n=2)
Trial: 9000657
Drug: HAT 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HAT 0.5 mg/kg every other week (n=3)
Trial: 9000657
Drug: HAT 1
RxNorm normalized name: brompheniramine maleate/pseudoephedrine HCl/codeine phosphat 1.3 mg-10 mg-6.3 mg/5 mL ORAL LIQUID (ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HAT 1 mg/kg every other week (n=3)
Trial: 8272759
Drug: Different inclusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Different inclusion criteria for treatment
Trial: 3548336
Drug: Low-dose controlled
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose controlled heparin anticoagulation
Trial: 30541572
Drug: Proprietary spearmint
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proprietary spearmint extract (PSE) 900 mg daily for 90 days
Trial: 27184721
Drug: Chemotherapy plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy plus bevacizumab (CT+bevacizumab)
Trial: 29777975
Drug: Chemotherapy alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy alone (CT)
Trial: 12974145
Drug: Lispro insulin
RxNorm normalized name: Lispro insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lispro insulin and metformin
Trial: 11453959
Drug: Human regular
RxNorm normalized name: Human regular insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Human regular insulin
Trial: 1534044
Drug: Amlodipine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine (5 or 10 mg/day od)
Trial: 1534044
Drug: Nifedipine s.r.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine s.r. (20 or 40 mg BID)
Trial: 3956558
Drug: 1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg/kg of pethidine im
Trial: 3956558
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg of extradural pethidine
Trial: 3956558
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg of extradural pethidine
Trial: 20137477
Drug: rhPTH (1-34)
RxNorm normalized name: rhPTH
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: rhPTH (1-34) 20 microg daily
Trial: 20979784
Drug: elcatonin 20
RxNorm normalized name: melatonin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: elcatonin 20 U weekly
Trial: 16703579
Drug: Aztreonam lysinate
RxNorm normalized name: Aztreonam
DrugBank: Aztreonam (DB00355)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aztreonam lysinate for inhalation (AI) 75 mg
Trial: 16703579
Drug: Aztreonam lysinate
RxNorm normalized name: Aztreonam
DrugBank: Aztreonam (DB00355)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aztreonam lysinate for inhalation (AI) 150 mg